Skip to main content
Figure 3 | Critical Care

Figure 3

From: Intravenous immunoglobulin for severe sepsis and septic shock: clinical effectiveness, cost-effectiveness and value of a further randomised controlled trial

Figure 3

Evidence on the clinical effectiveness of IVIG for severe sepsis (and septic shock): Forest plots for (a) fixed-effects model using inverse variance weights, and (b) random-effects model using inverse variance weights. Both evaluate IVIG and IVIGAM treatments versus control. IVIG, intravenous immunoglobulin; IVIGAM, immunoglobulin M-enriched polyclonal IVIG.

Back to article page

Critical Care

ISSN: 1364-8535